@article{TAU19126,
author = {Chloe L. Georgiou and Carmel Pezaro and Shomik Sengupta},
title = {Putting guidelines into practice: has the era of perioperative chemotherapy arrived?},
journal = {Translational Andrology and Urology},
volume = {7},
number = {Suppl 2},
year = {2018},
keywords = {},
abstract = {In the current landscape of bladder cancer management, marked survival differences exist between non-muscle invasive, muscle invasive and metastatic disease (5-year survival 95%, 50% and 6%, respectively) (1). The rationale for a multi-modal approach to muscle-invasive bladder cancer (MIBC) is to maximize curative treatment outcomes and prevent progression to metastatic disease.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/19126}
}